A prenatally diagnosed case of Meckel-Gruber syndrome with novel compound heterozygous pathogenic variants in the TXNDC15 gene.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
05 2019
Historique:
received: 13 10 2018
revised: 16 01 2019
accepted: 11 02 2019
pubmed: 10 3 2019
medline: 27 6 2019
entrez: 10 3 2019
Statut: ppublish

Résumé

Meckel-Gruber syndrome (MKS) is a well-known rare disease that can be detected on prenatal ultrasound. Meckel-Gruber syndrome has very heterogeneous etiology; at least, 17 genes have been described in association with MKS. The characteristic findings in fetuses affected by MKS are encephalocele (usually occipital), postaxial polydactyly, and polycystic dysplastic kidneys. However, the association of the TXNDC15 gene with MKS has been reported only once before in three consanguineous families. We report a new case of MKS diagnosed at 12 + 1 weeks of gestation with typical ultrasound findings, but with novel compound heterozygous pathogenic variants in the TXNDC15 gene identified by whole-exome sequencing (WES). This is the second clinical report supporting TXNDC15 as a novel causative gene of MKS, and the first describing a case in a non-consanguineous family with causative compound heterozygous mutations. Meckel-Gruber syndrome is a very heterogeneous syndrome in terms of the associated causal genes. In the first-line diagnosis, we used an next-generation sequencing (NGS)-based large gene panel, but only 10 MKS genes were available on the platform used. In the case of prenatal ultrasound findings that are highly suggestive of MKS and a negative NGS MKS gene panel, WES should also be performed to not miss rare gene associations.

Sections du résumé

BACKGROUND
Meckel-Gruber syndrome (MKS) is a well-known rare disease that can be detected on prenatal ultrasound. Meckel-Gruber syndrome has very heterogeneous etiology; at least, 17 genes have been described in association with MKS. The characteristic findings in fetuses affected by MKS are encephalocele (usually occipital), postaxial polydactyly, and polycystic dysplastic kidneys. However, the association of the TXNDC15 gene with MKS has been reported only once before in three consanguineous families.
METHODS
We report a new case of MKS diagnosed at 12 + 1 weeks of gestation with typical ultrasound findings, but with novel compound heterozygous pathogenic variants in the TXNDC15 gene identified by whole-exome sequencing (WES).
RESULTS
This is the second clinical report supporting TXNDC15 as a novel causative gene of MKS, and the first describing a case in a non-consanguineous family with causative compound heterozygous mutations.
CONCLUSIONS
Meckel-Gruber syndrome is a very heterogeneous syndrome in terms of the associated causal genes. In the first-line diagnosis, we used an next-generation sequencing (NGS)-based large gene panel, but only 10 MKS genes were available on the platform used. In the case of prenatal ultrasound findings that are highly suggestive of MKS and a negative NGS MKS gene panel, WES should also be performed to not miss rare gene associations.

Identifiants

pubmed: 30851085
doi: 10.1002/mgg3.614
pmc: PMC6503012
doi:

Substances chimiques

Membrane Proteins 0
TXNDC15 protein, human 0
Thioredoxins 52500-60-4

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e614

Subventions

Organisme : Tartu Ülikool
ID : PUT355
Pays : International
Organisme : Tartu Ülikool
ID : PRG471
Pays : International

Informations de copyright

© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

Références

Front Pediatr. 2017 Nov 20;5:244
pubmed: 29209597
Nat Genet. 2018 Mar;50(3):460-471
pubmed: 29459677
Arch Gynecol Obstet. 2017 Apr;295(4):897-906
pubmed: 28283827
Eur J Hum Genet. 2015 Jun;23(6):746-52
pubmed: 25182137
Mol Cell Probes. 2015 Oct;29(5):299-307
pubmed: 26003401
Am J Med Genet. 1984 Aug;18(4):691-8
pubmed: 6486168
Am J Obstet Gynecol. 1997 Feb;176(2):316-9
pubmed: 9065174
Nat Genet. 2006 Feb;38(2):155-7
pubmed: 16415886
Genome Biol. 2016 Nov 28;17(1):242
pubmed: 27894351
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Mol Genet Genomic Med. 2019 May;7(5):e614
pubmed: 30851085
Clin Genet. 2007 Nov;72(5):454-9
pubmed: 17935508
Arch Gynecol Obstet. 2017 Sep;296(3):455-463
pubmed: 28634753
J Matern Fetal Neonatal Med. 2016;29(12):2013-6
pubmed: 26333300

Auteurs

Konstantin Ridnõi (K)

Centre for Perinatal Care, Women's Clinic, East-Tallinn Central Hospital, Tallinn, Estonia.
Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Marek Šois (M)

Fetal Ultrasound Screening Centre, Tallinn, Estonia.

Eve Vaidla (E)

United Laboratories, Department of Clinical Genetics, Tartu University Hospital, Tartu, Estonia.

Sander Pajusalu (S)

United Laboratories, Department of Clinical Genetics, Tartu University Hospital, Tartu, Estonia.
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.

Larissa Kelder (L)

Centre of Pathology, Diagnostic Clinic, East-Tallinn Central Hospital, Tallinn, Estonia.

Tiia Reimand (T)

United Laboratories, Department of Clinical Genetics, Tartu University Hospital, Tartu, Estonia.
Department of Biomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Katrin Õunap (K)

Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
United Laboratories, Department of Clinical Genetics, Tartu University Hospital, Tartu, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH